Mesothelioma

These kinds of talc lawsuits have been underway for at least two decades.

The first lawsuit involving industrial talc exposure and mesothelioma was filed in 2006. The first lawsuit to claim that talcum powder caused ovarian cancer was filed in 2009. Multi million-dollar verdicts have been awarded in these cases.

The Dugan Law Firm has a co-counsel arrangement with Frank D'Amico Jr. Attorney to handle these cases. For more information, call (504) 525-7272.

We are Invokana Gangrene Lawsuit Attorneys

Invokana has been linked to Gangrene of the genitals, Genital Amputations, Kidney Damage, Ketoacidosis

Invokana can cause gangrene of the genitals, a flesh-eating gential infection.  Invokana also increases the risk of genitals amputations. The FDA released this warning August 29, 2018: The U.S. Food and Drug Administration (FDA) is warning that cases of a rare but serious infection of the genitals and area around the genitals have been reported with the class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors. This serious rare infection, called necrotizing fasciitis of the perineum, is also referred to as Fournier’s gangrene. We are requiring a new warning about this risk to be added to the prescribing information of all SGLT2 inhibitors and to the patient Medication Guide.

These medications include Invokana, Invokamet, Farxiga, and Jardiance. Invokana has been linked to kidney failure. According to the American Diabetes Association, ketoacidosis – also known as acidosis or diabetic ketoacidosis (DKA) – causes one to produce dangerous levels of blood acids, or keytones, which can lead to diabetic coma and can be fatal. The FDA is now reviewing the safety of all SGLT2 inhibitors to determine if the risk of ketoacidosis should be noted on the drugs’ labels, and also whether Invokana raises the risk of amputations.

If you were hospitalized with infection or gangrene of the genitals after taking Invokana or a similar diabetes medication,  or if you lost a limb or limbs after taking one of these drugs, contact Dugan Law Firm TODAY at (866) 328-7670. LEARN MORE HERE.

Image

It has come to light that an alarming number of Catholic priests and other clergies have abused thousands of children and young adults over the last several decades.  Recent developments in Pennsylvania and several other states have uncovered the practice of priests victimizing children in their charge impossible to ignore.  Many states are now realizing that victims of child sex abuse often deny their own past circumstances for decades. Often, child sex abuse victims try to block out the memories of abuse. As a result, victims may suffer due to self-medication, depression and even suicide. It can take victims decades to reach a point of coming to terms with the abuse in such a way that they are emotionally ready to face it and to file a lawsuit against their abuser. Our clergy abuse team is working to bring civil justice to those victimized by priests and other members of the clergy. We realize the delicate nature of this type of abuse and our team is trained to handle your case in a professional, compassionate and confidential manner.

The Pennsylvania Grand Jury Report:  In August 2018, the problem of clergy sex abuse was brought to the forefront. During this time the Pennsylvania Grand Jury showed a shocking number of priest abuse cases that went unreported by the church.  The Pennsylvania grand jury, which convened for two years, concluded that at least 300 priests had sexually abused more than 1,000 children and underage young people in a period spanning six decades.  Church documents revealed the church’s moral failure regarding hiding abuse.  The typical Catholic dioceses failed to “out” the abusers and protect the children in their charge.  Moreover, the jury found repeatedly that the church failed to dismiss and punish those accused by multiple eyewitnesses of sexual abuse.  We want to help abused people find justice. We look forward to speaking with you regarding a potential clergy abuse claim.

Confidential Case Consultation

Call us today for a free, confidential case consultation. We work on a contingency fee basis; we don’t get paid unless we win compensation for our clients. Contact Dugan Law Firm TODAY at (866) 328-7670.


Current Litigation


VIEW ALL CURRENT CASES

NFL & NCAA CONCUSSIONSGet the Facts


READ MORE

Current Litigation


  • In Re: Fosamax Product Liability Litigation, (MDL No. 1789) (2006-Present) USDC for the Southern District of New York, Judge Keenan. Member: Plaintiffs’ Steering Committee.
  • In Re: Celexa/Lexapro Product Liability Litigation, (MDL 2067) (2009-Present) USDC for the District of Massachusetts, Judge Nathaniel M. Gorton.
  • In Re: Fosamax Femur Litigation, (MDL No. 2243) (2011–Present) USDC for the District of New Jersey, Judge Joel A. Pisano. Member: Plaintiffs’ Steering Committee.
  • In Re: Avandia Marketing and Sales Practices Litigation (MDL No. 1871) (2009- Present) USDC for the Eastern District of Pennsylvania, Judge Cynthia M. Rufe. Member: Co-Lead Counsel for Plaintiffs’ Third-Party Payors.
  • In Re: Effexor Antitrust Litigation (11-CV-05590) (2011-Present) USDC for the District of New Jersey, Judge Joel A. Pisano. Member: Executive Committee for Indirect Purchasers.
  • In Re: Nexium (Esomeprazole) Antitrust Litigation, (MDL No. 2409) (2012-Present), USDC for the District of Massachusetts, Judge William G. Young. Member: Plaintiffs’ Executive Committee for Indirect Purchasers.
  • In Re: Fresenius Granuflo/Naturallte Dialysate Products Liability Litigation, (MDL No. 2428 (2013-Present) USDC for the District of Massachusetts, Judge Douglas P. Woodlock. Member: Plaintiffs’ Steering Committee.
  • In Re: Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation, (MDL No. 2445) (2013–Present), USDC for the Eastern District of Pennsylvania, Judge Mitchell S. Goldberg. Member: Plaintiffs’ Executive Committee for Indirect Purchasers.
  • In Re: Niaspan Antitrust Litigation, (MDL No. 2460) (2013-Present). USDC for the Eastern District of Pennsylvania, Judge Jan E. DuBois. Member: Plaintiffs’ Executive Committee for Indirect Purchasers.
  • In Re: Lidoderm Antitrust Litigation, (MDL No. 2521) (2014-Present). USDC for the Northern District of California, Judge William H. Orrick. Member: Plaintiffs’ Executive Committee for Indirect Purchasers.
  • In Re: Generic Pharmaceuticals Pricing Antitrust Litigation, (MDL No. 2724) (2017 – Present), USDC for the Eastern District of Pennsylvania, Judge Cynthia M. Rufe. Member Plaintiffs’ Steering Committee.

Settlements | Awards


  • In Re: Synthroid Marketing Litigation, (MDL No. 1182) (1997-2004) USDC for the Northern District of Illinois, Eastern Division, Judge Elaine E. Bucklo. Co-Lead Counsel for a class of third party-payors. Settlement: $45,000,000.00
  • In Re: Diet Drugs Litigation, (MDL No. 1203) (1997-2002) USDC for the Eastern District of Pennsylvania, Judge Lewis C. Bechtle. Co-Lead Counsel for a large group of individually represented third-party payors. Settlement: $35,000,000.00
  • In Re: Propulsid Litigation, (MDL No. 1355) (2000-Present) USDC for the Eastern District of Louisiana, Judge Eldon Fallon. Member: Plaintiffs’ Steering Committee. Settlement: $90,000,000.00
  • In Re: Rezulin Products Liability Litigation, (MDL No. 1348) (2000-2008) USDC for the Southern District of New York, Judge Lewis A. Kaplan. Mr. Dugan was appointed by the court as Liaison Counsel to a class of Health Benefit Providers. Settlement: $22,500,000.00
  • In Re: Industrial Life Insurance Litigation, (MDL No. 1371) (2000-2007) USDC for the Eastern District of Louisiana, Judge Martin L.C. Feldman, presiding. Member: Plaintiffs’ Executive Committee. Settlement: $50,000,000.00
  • In Re: Inter-Op Hip Prosthesis Product Liability Litigation, (MDL No. 1401) (2001-2008) USDC for the Northern District of Ohio, Eastern Division, Judge Kathleen O’Malley. Member: Plaintiffs’ Steering Committee. Settlement: $1,200,000,000.00
  • In Re: Baycol Products Liability Litigation, (MDL No. 1431) (2001-2007) USDC for the District of Minnesota, Judge Michael Davis. Member: Plaintiffs’ Steering Committee. Settlement: 1,000,000,000.00
  • In Re: Meridia Products Liability Litigation, (MDL No. 1481) (2002-2006) USDC for the Northern District of Ohio, Judge James S. Gwin. Member: Plaintiffs’ Steering Committee.
  • In Re: Serzone Products Liability Litigation, (MDL No. 1477) (2002-2007) USDC for the Southern District of West Virginia, Judge Joseph R. Goodwin. Member: Plaintiffs’ Steering Committee. Settlement: $90,000,000.00
  • In Re: Neurontin Marketing & Sales Practices Litigation, (MDL No. 1629) (2004-Present) USDC for the District of Massachusetts, Judge Patti B. Saris. Member: Plaintiffs’ Steering Committee. Settlement: $325,000,000.00
  • In Re: Vioxx Products Liability Litigation, (MDL No. 1657) (2005-Present) USDC for the Eastern District of Louisiana, Judge Fallon, Magistrate Judge Knowles. Member: Co-Chair Purchase Claims Committee. Settlement: $80,000,000.00
  • In Re: Zyprexa Marketing and Sales Practices Litigation, (MDL No. 1596) (2005-2013) USDC for the Eastern District of New York, Judge Weinstein and Magistrate Judge Chrein. Member: Co-Lead Counsel for the Purchase Claims. Settlement: $4,500,000.00
  • In Re: Bextra and Celebrex Marketing and Sales Practices and Products Liability Litigation, (MDL No. 1699) (2006-2010) USDC for the Northern District of California, Judge Breyer. Member: Purchase Claims Committee. Settlement: $89,000,000.00
  • In Re: Oxycontin Marketing and Sales Practices Litigation (2007-2009) USDC for the Southern District of New York, Judge Koel. Co-lead counsel for third-party payors. Settlement: $20,000,000.00
  • In Re: Vytorin Marketing, Sales Practice, and Products Liability, (MDL No. 1938) (2008-2010) USDC for the District of New Jersey, Judge Dennis M. Cavanaugh. Member: Plaintiffs’ Steering Committee. Settlement: $45,000,000.00
  • In Re: National Football Players’ Concussion Injury, (MDL No. 2323) (2012–Present), USDC for the Eastern District of Pennsylvania, Judge Anita Brody. Member: Plaintiffs’ Steering Committee. Settlement: Uncapped class action settlement pending court approval.
  • In Re: Skelaxin (Metaxalone) Antitrust Litigation, (MDL No. 2343) (2012-2014), USDC for the Eastern District of Tennessee, Judge Curtis L. Collier. Member: Plaintiffs’ Executive Committee for Indirect Purchasers. Settlement: $4,000,000.00
  • In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation, (MDL No. 2385) (2012-Present), USDC for Southern District of Illinois, Judge David R. Herndon. Member: Plaintiffs’ Steering Committee. Settlement: $650,000,000.00
  • In Re: National Collegiate Athletic Association Student-Athlete Concussion Litigation, (MDL No. 2492) (2014–Present), USDC for the Northern District of Illinois, Judge John Z. Lee. Member: Plaintiffs’ Steering Committee. Pending $75,000,000.00 medical monitoring settlement pending court approval.
  • In Re: Prograf Antitrust Litigation, (MDL No. 2242) (2011-2016) USDC for District of Massachusetts, Judge Rya W. Zobel. Member: Co-Lead Counsel for Indirect Purchasers.